Clinical Impact of TP53 Mutations in Patients with Head and Neck Cancer Who Were Treated with Targeted Therapies or Immunotherapy.

Saved in:
Bibliographic Details
Title: Clinical Impact of TP53 Mutations in Patients with Head and Neck Cancer Who Were Treated with Targeted Therapies or Immunotherapy.
Authors: Kang, Eun Joo1 (AUTHOR), Hwang, Shinwon2 (AUTHOR), Lee, Yun-Gyoo3 (AUTHOR), Choi, Jong-Kwon4 (AUTHOR), Shin, Seong Hoon5 (AUTHOR), Choi, Yoon Hee6 (AUTHOR), Lee, Keun-Wook7 (AUTHOR), Lee, Hyun Woo8 (AUTHOR), Kim, Min Kyoung9 (AUTHOR), Lim, Seung Taek10 (AUTHOR), Yun, Hwan Jung11 (AUTHOR), Park, Sang-Gon12 (AUTHOR), Kim, Sangwoo13 (AUTHOR), Kim, Sung-Bae14 (AUTHOR) sbkim3@amc.seoul.kr, Kim, Hye Ryun15 (AUTHOR) NOBELG@yuhs.ac
Source: Cancer Research & Treatment. Jul2025, Vol. 57 Issue 3, p709-719. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:15982998
DOI:10.4143/crt.2024.836